Skip to main content

Written question asked by Jason McCartney (Conservative) on Tuesday, 17 March 2015, in the House of Commons. It was due for an answer on Thursday, 19 March 2015. It was answered by Jane Ellison (Conservative) on Tuesday, 24 March 2015 on behalf of the Department of Health.


Meningitis: Vaccination

Question

To ask the Secretary of State for Health, what steps he is taking with officials of his Department to expedite negotiations with GlaxoSmithKline on the meningitis B vaccine.

Answer

We are seeking to reach a positive conclusion to the negotiations with GlaxoSmithKline for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, as soon as possible.

The Department has had a number of meetings with the manufacturer and is continuing to meet.


Secondary information

Type
Written question
Reference
227878
Session
2014-15
Grouped for answer
Yes
Subjects
Vaccination Meningitis GlaxoSmithKline
Link
View this Written question on www.parliament.uk